KMR Group is currently conducting a benchmarking project related to Vaccine R&D and Clinical performance. The companies participating include some of the world’s leaders in Vaccine R&D.

The scope of the project extends across the full R&D spectrum. Detailed portfolio data, clinical data, sales information, and resource data is collected from each participant. The study provides information on investment, productivity, success rates, cycle time, pipeline, and sales. The results from this study will be released Q4 of this year.

Please fill out the form below if you would like us to reach out to you with more information.